[1] Basu S, Yudkin JS, Kehlenbrink S, et al. Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis. Lancet Diabetes Endocrinol, 2019; 7, 25−33. doi:  10.1016/S2213-8587(18)30303-6
[2] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet, 2016; 387, 1513−30. doi:  10.1016/S0140-6736(16)00618-8
[3] Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol, 2017; 5, 423−30. doi:  10.1016/S2213-8587(17)30097-9
[4] Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA, 2008; 299, 1320−34. doi:  10.1001/jama.299.11.1320
[5] Davies LE, Thirlaway K. The influence of genetic explanations of type 2 diabetes on patients' attitudes to prevention, treatment and personal responsibility for health. Public Health Genomics, 2013; 16, 199−207. doi:  10.1159/000353459
[6] O'Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science, 2005; 307, 370−3. doi:  10.1126/science.1104346
[7] Hsu CC, Kao WH, Coresh J, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA, 2005; 293, 2892−9. doi:  10.1001/jama.293.23.2892
[8] Luo JQ, Ren H, Banh HL, et al. The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus. Front Physiol, 2017; 8, 1031. doi:  10.3389/fphys.2017.01031
[9] Chaudhary R, Likidlilid A, Peerapatdit T, et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol, 2012; 11, 36. doi:  10.1186/1475-2840-11-36
[10] Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet, 2000; 1, 507−37. doi:  10.1146/annurev.genom.1.1.507
[11] Li T, Shi Y, Yin J, et al. The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis. Int Urol Nephrol, 2015; 47, 117−30. doi:  10.1007/s11255-014-0843-6
[12] Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol, 2006; 33, 279−308. doi:  10.1080/03014460600594513
[13] Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med, 2004; 141, 137−47. doi:  10.7326/0003-4819-141-2-200407200-00013
[14] McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology, 1999; 53, 1308−11. doi:  10.1212/WNL.53.6.1308
[15] Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997; 278, 1349−56. doi:  10.1001/jama.1997.03550160069041
[16] Al-Majed HT, Qasem JA, Al-Sherifi AK, et al. Association between apolipoprotein E-polymorphism and Ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in Kuwait. Arch Iran Med, 2011; 14, 385−8.
[17] Alharbi KK, Khan IA, Syed R. Association of apolipoprotein E polymorphism with type 2 diabetes mellitus in a Saudi population. DNA Cell Biol, 2014; 33, 637−41. doi:  10.1089/dna.2014.2461
[18] Atta MI, Abo Gabal K, El-Hadidi K, et al. Apolipoprotein E genotyping in Egyptian diabetic nephropathy patients. IUBMB Life, 2016; 68, 58−64. doi:  10.1002/iub.1460
[19] Erdogan M, Eroglu Z, Biray C, et al. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy. J Endocrinol Invest, 2009; 32, 219−22. doi:  10.1007/BF03346455
[20] Mehmet E, Zuhal E, Mustafa K, et al. The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers. Diabetes Metab Syndr, 2016; 10(1 Suppl 1), S30−33.
[21] Mustapic M, Popovic Hadzija M, Pavlovic M, et al. Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes. Metab Brain Dis, 2012; 27, 507−12. doi:  10.1007/s11011-012-9310-1
[22] Sun L, Wang S, Shi X, et al. Interactionsbetween APOE andM THFR M utationsisAssociated with the Risk for Type2 Diabetic Nephropathy. Journal of Medical Molecular Biology, 2013; 10, 95−9.
[23] Liang A, He S, Hua X, et al. Correlation between ApoE gene polymorphism and chronic cardiovascular disease and blood ipid levels of patients. International Journal of laboratory medicine, 2017; 38, 1601−2+1605.
[24] Liu W. FOXC2, APOE, eNOS gene polymorphism with type 2 diabetes in Yunnan Naxi correlation. Kunming Medical University, 2014.
[25] Chen X. Relationship between paraoxonase 1, paraoxonase 2 and apoliplprotein E gene polymorphisms and type 2 diabetes nephropathy. Fujian Medical University, 2006.
[26] Xiong Y, Pei H, Qian S, et al. Study on the correlation between dyslipidemia and apolipoprotein E gene polymorphism in Li nationality population T2DM patients. Chinese Journal of Diabetes, 2013; 21, 822−4.
[27] Liu W, Yang L, Nian X, et al. The correlation between ApoE gene polymorphism with type 2 diabetes in Yuannan Naxi minority. Chinese Journal of Diabetes, 2016; 24, 402−6.
[28] Tang L, Wang X, Yu K, et al. Correlativ e analysis of apolipoprotein B,E gene polymorphism and several common diseases in southern area of Zhejiang Province. Journal of Wenzhou Medical College, 2007; 1, 14−7.
[29] Ge B, Chen J, Tian G, et al. The relationship between apolipoprotein E polymorphism and dyslipidemia in patients with type 2 diabetes. China Medical Herald, 2013; 10, 17−9+23.
[30] Luo E, Yang Q, Li X. Analysis on the association between Apolipoprotein E Gene Polymorphism and renal Complications in Chinese Type 2 Diabetic Patients. Journal of Qiqihar University of Medicine, 2016; 37, 3130−2.
[31] Wang Y, Xiao Z, Huang P. Studies on relationshp between apolipoprotein E genotype polymorphism and diabetic nephropathy in Chinese Han population of Guangdong Province. Journal of practical Medicine, 2014; 30, 3090−2.
[32] Rong Y, Xie Y, Chen X, et al. Analysis fo the correlation among insulin resistance ApoE gene polymorphism and mild cognitive impairment. Hebei Medicine, 2013; 19, 1604−7.
[33] Yin YW, Qiao L, Sun QQ, H, et al. Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies. Metabolism, 2014; 63, 532−41. doi:  10.1016/j.metabol.2013.12.008
[34] Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003; 327, 557−60. doi:  10.1136/bmj.327.7414.557
[35] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994; 50, 1088−101. doi:  10.2307/2533446
[36] Singh PP, Naz I, Gilmour A, et al. Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract, 2006; 74, 95−102. doi:  10.1016/j.diabres.2006.03.013
[37] Errera FI, Silva ME, Yeh E, et al. Effect of polymorphisms of the MTHFR and APOE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. Braz J Med Biol Res, 2006; 39, 883−8. doi:  10.1590/S0100-879X2006000700005
[38] Inamdar PA, Kelkar SM, Devasagayam TP, et al. Apolipoprotein E polymorphism in non-insulin-dependent diabetics of Mumbai, India and its effect on plasma lipids and lipoproteins. Diabetes Res Clin Pract, 2000; 47, 217−23. doi:  10.1016/S0168-8227(99)00126-6
[39] Kwon MK, Rhee SY, Chon S, et al. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients. Diabetes Res Clin Pract, 2007; 77(Suppl 1), S228−232.
[40] Vauhkonen I, Niskanen L, Ryynanen M, et al. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med, 1997; 14, 748−56. doi:  10.1002/(SICI)1096-9136(199709)14:9<748::AID-DIA469>3.0.CO;2-N
[41] Eto M, Watanabe K, Iwashima Y, et al. Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes, 1986; 35, 1374−82. doi:  10.2337/diab.35.12.1374
[42] Guan J, Zhao HL, Baum L, et al. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant, 2009; 24, 1889−95. doi:  10.1093/ndt/gfn734
[43] Leiva E, Mujica V, Orrego R, et al. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile. Diabetes Res Clin Pract, 2005; 68, 244−9. doi:  10.1016/j.diabres.2004.09.017
[44] Liu L, Xiang K, Zheng T, et al. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem, 2003; 254, 353−8.
[45] Xie YQ, Wang H, Wu YP, et al. Association of APOE polymorphisms and insulin resistance with TCM syndromes in type 2 diabetes patients with macroangiopathy. Mol Med Rep, 2011; 4, 1219−23.
[46] Santos A, Salguero ML, Gurrola C, et al. The epsilon4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients. Ophthalmic Genet, 2002; 23, 13−9. doi:  10.1076/opge.23.1.13.2203
[47] Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis, 1995; 112, 145−59. doi:  10.1016/0021-9150(94)05409-C
[48] Ng MC, Baum L, So WY, et al. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet, 2006; 70, 20−8. doi:  10.1111/j.1399-0004.2006.00628.x
[49] Eto M, Horita K, Morikawa A, et al. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Clin Genet, 1995; 48, 288−92.
[50] Morbois-Trabut L, Chabrolle C, Garrigue MA, et al. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients. Diabetes Metab, 2006; 32, 270−5. doi:  10.1016/S1262-3636(07)70279-3
[51] Powell DS, Maksoud H, Charge SB, et al. Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes. Diabetes Res Clin Pract, 2003; 60, 105−10. doi:  10.1016/S0168-8227(02)00281-4
[52] Guangda X, Bangshun X, Xiujian L, et al. Apovarepsilon(4) allele increases the risk for exercise-induced silent myocardial ischemia in non-insulin-dependent diabetes mellitus. Atherosclerosis, 1999; 147, 293−6. doi:  10.1016/S0021-9150(99)00198-7
[53] Zhang W, Zhang G, Zhang H, et al. Relationship between Apo E gene polymorphism and type 2 diabetes mellitus with its cardiovascular complication in Chinese. Medical Journal of Chinese Civil Administration, 2000; 4, 206−9.
[54] Zhang X, Liu B, Bai H, et al. Study on Apolipoprotein E Gene Polymorphism in Chinese Type 2 Diabetes Mellitus. J Sichuan Univ (Med Sci Edi), 2003; 1, 75−7.
[55] Sun L, Wang S, Shi X, et al. Interactionsbetween APOE andM THFR M utationsisAssociated with the Risk for Type2 Diabetic Nephropathy. J Med Mol Biol, 2013; 10, 95−9.
[56] Hua F, Liu W, Hu W, et al. Research on the association of ApoE gene polymorphism and type 2 diabetes mellitus with nephropathy. Suzhou Univers Ity Journal of Medical Science, 2006; 05, 837−838+860.
[57] Guo J, Li P, Su Z. Preliminary analysis on relationship between ApoE gene polymorphism and type 2 diabetes. Journal of Tianjin Medical University, 2003; 4, 532−4.
[58] Shen H, Liu L, Xiang K, et al. Relationship between ApoE gene polymorphism and type 2 diabetes mellitus with its nephropathy in Chinese. Chinese Journal of Diabetes, 2002; 1, 2−4.
[59] Zheng Y, Sun R, Li X, et al. Relationshipbetween ApoE gene polymorphism and type 2 diabetes mellitus with its cardiovascular complications in Chinese. Chin J Endocrinol Metab, 1998; 1, 14−7.
[60] Hua F, Shen Y, Hua W, et al. Association of carrier protein E gene polymorphism with diabetes mellitus with gallstone. Jiangsu Med J, 2004; 3, 182−4.
[61] Xiang GD, Yang XJ, Ding XH, et al. The distribution of Apolipoprotein E genotype among different vascular complications in non-insulin-dependent diabetes mellitus. Chinese Journal of Medical Genetics, 1995; 4, 197−200.
[62] Xiang G, He Y, Le L, et al. The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM. Natl Med J China, 1999; 5, 339.
[63] Shen Q, Chen X, Li P, et al. Relationship between polymorphism of APOE gene and plasma catenin and protein C in elderly type 2 diabetes mellitus. F J Medical Journal, 2002; 1, 75−7.
[64] Zhou J, Xue Y, Guan Y, et al. Association Study of Apolipoprotein E Gene Polymorphism and Cerebral Infarction in Type 2 Diabetic Patients. HEREDITAS, 2005; 27, 35−8.
[65] Xiang G, Jiang W, Hu T. Apolipoproteine 4 allele is associated with the decrease of endothelium-dependent arterial dilation in female patients with type 2 diabetes mellitus. Chin J Endocrinol Metab, 2005; 21, 9−12.
[66] Long J, Yang S, Gao J, et al. The Determination of Apolipoprotein E Genetic Polymorphism in Diabetics. Journal of Navy Medicine, 1999; 1, 42−4.
[67] Liang S, Cheng H, Guan H, et al. Relationship of angiotensin converting enzyme and apolipoprotein E gene polymorphism with diabetic retinopathy. International Journal of Ophthamology, 2005; 5, 1156−9.
[68] Gu L, Pan M, Chen H, et al. Study in the Relationships between Apolipoprotein E Gene Polymorphism and Diabetic Retinopathy. Chinese Journal of Misdiagnostics, 2004; 4, 664−6.
[69] Yang X, Ding X, Fan Y, et al. Relationship between coronary heart disease and apolipoprotein E genotype in patients with type 2 diabetes mellitus in Wuhan. Chinese Journal of Endocrine and Metabolism, 1995; 4, 206−210+250.
[70] Qiu Y. Relationship between variation of apolipoprotein E gene and type 2 diabetes mellitus with carotid atherosclerosis. Zhejiang Practical Medicine, 2008; 3, 157−159+168.
[71] Guo J, Xu X. Association of apolipoprotein E gene polymorphism, hypersensitive C-reactive protein and type 2 diabetes mellitus with coronary heart disease. Shuanxi Medical Journal, 2007; 12, 1613−1616.
[72] Xiong Y, Liu S, Yang Y, et al. The Association of Apolipoprotein E Genotype with Type 2 Diabetes Mellitus. Chinese Journal of Microcirculation, 2008; 18, 28−29,33,23.
[73] Xiang Q, Song D, Liu H, et al. The study of the association of apolipoprotein E(ApoE) gene polymorphism with diabetic nephropathy in type 2 diabetic patients. Chinese Journal of Diabetes, 2010; 18, 185−6.
[74] Zhang G, Xu Z. Study on the relationship between apolipoprotein E(Apo E)gene polymorphism and Chinese patients with type 2 diabetes mellitus and diabetogenous nephropathy(DN). Zhejiang Journal of Clinical Medicine, 2007; 9, 735−6.
[75] Zhang L. Association between apolipoprotein E gene polymorphism and type II diabetic nephropathy. Acta Universitatis Medicinalis Anhui, 1999; 34, 102.
[76] Xiong B, Zhu X. Relativity between apolipoprotein E,fatty acid binding 2 polymorphism and type 2 diabetes mellitus patients with nephropathy. CLINICAL FOCUS, 2005; 20, 367−70.
[77] Qingfu Dai. A studies on the relationship between apo e sevels and genotypes in diabetie-nephropathy. Modern Journal of Integrated Chinese and Western Medicine, 2000; 23, 2321−2.
[78] Anthopoulos PG, Hamodrakas SJ, Bagos PG. Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab, 2010; 100, 283−91. doi:  10.1016/j.ymgme.2010.03.008
[79] Xu Q, Yang G, Li L, et al. Association of ApoE gene polymorphisms and type 2 diabetes mellitus in Chinese population: a Meta-analysisstudy. Cta Academiae Medicinae Militaris Tertiae, 2010; 32, 164−8.
[80] Long A, Huang X, Shen M, et al. Meta-Analysis: Association of Apolipoprotein E Gene Polymorphism with Type 2 Diabetes Mellitus in Chinese Population. The Journal of Evidence-Based Medicine, 2013; 13, 57−60.
[81] Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res, 1992; 33, 447−54.
[82] Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA, 2007; 298, 1300−11. doi:  10.1001/jama.298.11.1300